For women aged 35+ or affected by PCOS,
the AMH-value is crucial.
![](https://profertil-female.tn/wp-content/uploads/2021/09/Grafik_AMH-Level-Guideline_V2_EN@2x-1024x869.png)
PROFERTIL® female increases the AMH level when it is too low in women aged 35+ and also decreases the AMH level when it is too high in women affected by PCOS. An AMH value in the green range (approx. 1.0 to below 6.0 ng/ml) indicates conditions are good for female fertility.
Ficicioglu C. et al.; Gynecol Endocrinol (2014) May;30(5):372-6.
Merdassi G. et al.; Fertil Steril (2013) Sept;100(3):S157.
![](https://profertil-female.tn/wp-content/uploads/2021/09/new-study@2x.png)
In women 35+ fertility is significantly impaired:
AMH level and ovarian reserve decrease
![](https://profertil-female.tn/wp-content/uploads/2022/07/amh-level-in-the-course-of-age-1024x404-1.png)
The AMH value (Anti-Müllerian Hormone) denotes an indicator of female fertility and can be crucial for the success of an IVF treatment. A low AMH level can indicate a low egg cell reserve, because the serum AMH level correlates strongly with the number of growing follicles.*
*Gomez R. et al.; Arch Gynecol Obstet (2016) 293:667–673.
![](https://profertil-female.tn/wp-content/uploads/2021/09/new-study@2x.png)
A regular cycle with ovulation is an important prerequisite to get pregnant: Regular menstrual cycle and restored ovulation thanks to PROFERTIL® female.
![](https://profertil-female.tn/wp-content/uploads/2022/07/Wirkungs-Icon_1_EN_rz-e1631014692311.png)
Regular menstrual cycle
Optimization of luteal phase duration after 3-months regimen (defined as days from ovulation to menstruation)
A regular cycle can be easily observed.
![](https://profertil-female.tn/wp-content/uploads/2022/07/journal-endocrinology-graphic-1.png)
![](https://profertil-female.tn/wp-content/uploads/2022/07/Wirkungs-Icon_2_DE_rz@2x-1.png)
Restored regular ovulation
The occurrence of ovulation was improved (dated to day 15 or verified with LH-testing and measured by transvaginal ultrasound).
![](https://profertil-female.tn/wp-content/uploads/2022/07/journal-endocrinology-graphic-2.png)
Lipovac M. et al., Gynecol Endocrinol. 2022 Apr;38(4):310-313.
![](http://staging.netzkundig.com/profertil-female/wp-content/uploads/2021/09/no-one-claim-english@2x.png)
![](http://staging.netzkundig.com/profertil-female/wp-content/uploads/2021/09/packshot-hormoe-free.png)